Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2.
Saved in:
| Title: | Hypoxia-inhibited miR-338-3p suppresses breast cancer progression by directly targeting ZEB2. |
|---|---|
| Authors: | He J; Department of Breast Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China., Wang J; Department of Breast Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China., Li S; Department of Urology Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China., Li T; Department of Urology Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China., Chen K; Department of Hepatobiliary and Pancreatic Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China., Zhang S; Department of Urology Surgery, the First Affiliated Hospital, Zhengzhou University, Zhengzhou, China. |
| Source: | Cancer science [Cancer Sci] 2020 Oct; Vol. 111 (10), pp. 3550-3563. Date of Electronic Publication: 2020 Aug 13. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1349-7006 |
|---|---|
| DOI: | 10.1111/cas.14589 |
